Related Experiment Video

Updated: Feb 1, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.0K

Angiogenesis: a target for cancer therapy

Giampaolo Tortora1, Davide Melisi, Fortunato Ciardiello

  • 1Division of Medical Oncology, Department of Molecular and Clinical Endocrinology and Oncology, Università di Napoli Federico II, Via S. Pansini 5, 80131 Naples, Italy. gtortora@unina.it

Current Pharmaceutical Design
|February 3, 2004
PubMed

Insights

New antiangiogenic drugs targeting tumor neoangiogenesis are emerging. Optimizing their combination with conventional therapies requires further research into treatment timing and sequencing.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Neoangiogenesis, the formation of new blood vessels, is crucial for tumor growth and spread.
  • Identifying key molecules in neoangiogenesis has led to targeted antiangiogenic agents.
  • Integrating antiangiogenic drugs with standard treatments is promising but requires optimized strategies.

Purpose of the Study:

  • To review the signal transduction pathways of angiogenic molecules.
  • To discuss the development and clinical translation of specific antiangiogenic inhibitors.
  • To explore future perspectives in antiangiogenic therapy.

Main Methods:

  • Literature review of signal transduction mechanisms.
  • Analysis of clinical studies on antiangiogenic inhibitors.
  • Discussion of emerging therapeutic strategies.

Main Results:

  • Detailed overview of molecular mechanisms driving neoangiogenesis.
  • Summary of clinical trial outcomes for various antiangiogenic agents.
  • Identification of challenges and opportunities in combined treatment protocols.

Conclusions:

  • Antiangiogenic therapy holds significant potential in cancer treatment.
  • Further investigation is needed to determine optimal combination strategies and timing.
  • Future research should focus on novel targets and personalized approaches to antiangiogenic therapy.

More Related Videos

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.5K
Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring08:45

Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring

Published on: November 13, 2012

14.3K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.8K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.5K
Group Therapy01:26

Group Therapy

Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
434